Abstract:Parvovirus B19 frequently infects children and targets cells of the erythroid lineage. Although healthy children rarely suffer severe disease, children with sickle cell disease (SCD) can experience transient red cell aplasia (TRCA), hospitalization, and life-threatening anemia upon first virus exposure. Given that children with SCD can also suffer chronic inflammation and that parvovirus B19 has been associated with autoimmune disease in other patient populations, we asked if parvovirus B19 infections contributed to acute and chronic immune abnormalities in children with SCD. Nineteen hospitalized patients with SCD and parvovirus B19–induced TRCA were evaluated. Blood tests included CBC, flow cytometry, and total antibody isotype analyses. Cytokine/chemokine analyses were performed on nasal wash (NW) samples, representing a common site of viral entry. Unusually high white blood cell count (WBC) and absolute neutrophil count (ANC) values were observed in some patients. A correlation matrix with Day 0 values from the 19 patients then identified two mutually exclusive phenotype clusters. Cluster 1 included WBC, ANC, absolute reticulocyte count (ARC), absolute lymphocyte count (ALC), lactate dehydrogenase (LDH), NW cytokines/chemokines, % naïve cells among B cell and T cell populations, and parvovirus-specific IgG. This cluster was negatively associated with virus load, suggesting a signature of successful adaptive immunity and virus control. Cluster 2 included virus load, % CD38+CD24− cells among CD19+ B cells (termed 'plasmablasts' for simplicity), % HLA-DRlow cells among CD19+ B cells, IgG4, and % memory phenotypes among B cell and T cell populations. Plasmablast percentages correlated negatively with parvovirus-specific IgG, possibly reflecting a non-specific trigger of cell activation. All patients were released from the hospital within 1 week after admission, and the highest WBC and ANC values were eventually reduced. Nonetheless, a concern remained that the acutely abnormal immune profiles caused by parvovirus B19 infections could exacerbate chronic inflammation in some patients. To avoid the numerous sequelae known to affect patients with SCD following hospitalizations with parvovirus B19, rapid development of a parvovirus B19 vaccine is warranted.

Distinct clinical features of transplanted children with Parvovirus B19 infection

Case Report: Parvovirus B19 infection complicated by hemophagocytic lymphohistiocytosis in a heart-lung transplant patient

Towards the Antiviral Agents and Nanotechnology-Enabled Approaches Against Parvovirus B19

Pure Red Cell Apalsia Caused by Infection of Human Parvovirus B19 Post-Renal Transplantation: 8 Cases Report and Review

Clinical Presentations of Parvovirus B19: A Case Series

Clinical Characteristics of Human Parvovirus B19 Infection after Allogeneic Stem Cell Transplantation

Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients

SARS-CoV-2 Infection in Transplant-Related Biology: Where Do We Stand?

Immune Reconstitution and Survival of Patients with Parvovirus B19 Related Pure Red Cell Aplasia after Haplo-Pbsct

Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review

The Relation Between the Parvovirus B19 and Pregnancy

[Parvovirus B19 infections in adults]

Immune Cell Profiles of Patients with Sickle Cell Disease during Parvovirus B19–Induced Transient Red Cell Aplasia

Long‐term Remission of Recurrent Severe Anemia As a Result of Parvovirus B19 Infection in a Pediatric Renal Transplant Recipient

Human Parvovirus B19 Infection Induced Pure Red Cell Aplasia in Liver Transplant Recipients

The epidemiological and genetic characteristics of human parvovirus B19 in patients with febrile rash illnesses in China

Donor-Derived Human Parvovirus B19 Infection in Kidney Transplantation

Clinical utility of immune function based on IFN-γ monitoring of lymphocyte subsets for parvovirus B19 infection in renal recipients

Lymphocytic Myocarditis in Children with Parvovirus B19 Infection: Pathological and Molecular Insights

Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant

Dose‐by‐dose Virological and Hematological Responses to Intravenous Immunoglobulin in an Immunocompromised Patient with Persistent Parvovirus B19 Infection